Friday Feb 3 | PR-inside.com
ImClone Systems Incorporated: Company Profile and SWOT Analysis - new ...
The company is principally focused on growth factor blockers and angiogenesis inhibitors for treating a variety of cancers.
Bank Analyst Likes Dendreon's New CEO, Goldman Thinks Focus Media Share Lag Overdone
Dendreon Corp. : Deutsche Bank said Dendreon's new CEO, John Johnson, has a history of M&A and his fresh perspective might benefit the company's near-term strategy.
Dendreon Announces CEO and Chairman Succession Plan
February 1, 2012 - Dendreon Corporation today announced that its Board of Directors has elected John H. Johnson to the position of president and chief executive officer , to succeed Mitchell H. Gold, MD, who has served as president and CEO for nearly a decade.
Carl Icahn Issues Open Letter to Shareholders of Oshkosh Corporation
Oshkosh put out an investor presentation indicating that I have a "mixed" track record of delivering value to shareholders.